Effect of higher minimum inhibitory concentrations of quaternary ammonium compounds in clinical E. coli isolates on antibiotic susceptibilities and clinical outcomes

Journal of Hospital Infection

Volumn 79, Issue 2, 2011, Pages 141-146

  Buffet Bataillon, S ^a,c   Branger, B ^b   Cormier, M ^a,c   Bonnaure Mallet, M ^a,c   Jolivet Gougeon, A ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b Sécurité Naissance Naître ensemble ^*  (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic; Biofilm; Escherichia coli; Hypermutation; Minimum inhibitory concentrations; Quaternary ammonium compounds

Indexed keywords

AMOXICILLIN; BENZALKONIUM CHLORIDE; COTRIMOXAZOLE; CRYSTAL VIOLET; DIDECYLDIMETHYLAMMONIUM CHLORIDE; NALIDIXIC ACID; QUATERNARY AMMONIUM DERIVATIVE; RIFAMPICIN; TOBRAMYCIN;

ADULT; AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BENZALKONIUM COMPOUNDS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; PROGNOSIS; QUATERNARY AMMONIUM COMPOUNDS; TREATMENT OUTCOME;

EID: 80052273664     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.06.008     Document Type: Article

References (34)

1. Sabuncu E., David J., Bernede-Bauduin C., et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009, 6:e1000084.
2. Tezel U., Pierson J.A., Pavlostathis S.G. Effect of polyelectrolytes and quaternary ammonium compounds on the anaerobic biological treatment of poultry processing wastewater. Water Res 2007, 41:1334-1342.
3. Bloomfield S.F. Significance of biocide usage and antimicrobial resistance in domiciliary environments. J Appl Microbiol 2002, 92:144S-157S.
4. Gilbert P., McBain A.J. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 2003, 16:89-208.
5. Mycock G. Methicillin/antiseptic-resistant Staphylococcus aureus. Lancet 1985, 2:949-950.
6. Russell A.D. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 2002, 92:21S-135S.
7. Sheldon A.T. Antiseptic " resistance": real or perceived threat?. Clin Infect Dis 2005, 40:650-1656.
8. Kitao T., Ishimaru M., Nishihara S. Detection of biofilm-producing and methicillin resistance genes in Staphylococcus epidermidis isolated from healthy humans and in blood culture tests. J Infect Chemother 2010, 16:170-173.
9. Richardson A.R., Yu Z., Popovic T., Stojiljkovic I. Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci USA 2002, 99:6103-6107.
10. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
11. Friedman N.D., Kaye K.S., Stout J.E., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
12. McKibben L., Horan T., Tokars J.I., et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005, 33:217-226.
13. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections 1988. Am J Infect Control 1988, 16:128-140.
14. Allardet-Servent A., Bouziges N., Carles-Nurit M.J., Bourg G., Gouby A., Ramuz M. Use of low-frequency-cleavage restriction endonucleases for DNA analysis in epidemiological investigations of nosocomial bacterial infections. J Clin Microbiol 1989, 27:2057-2061.
15. Stepanovic S., Vukovic D., Hola V., et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007, 115:891-899.
16. LeClerc J.E., Li B., Payne W.L., Cebula T.A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 1996, 274:1208-1211.
17. Baquero M.R., Nilsson A.I., Turrientes Mdel C., et al. Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. J Bacteriol 2004, 186:5538-5542.
18. Mickey R.M., Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989, 129:125-137.
19. Ioannou C.J., Hanlon G.W., Denyer S.P. Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51:296-306.
20. Walsh S.E., Maillard J.Y., Russell A.D., Catrenich C.E., Charbonneau D.L., Bartolo R.G. Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. J Appl Microbiol 2003, 94:240-247.
21. Penna T.C., Mazzola P.G., Silva Martins A.M. The efficacy of chemical agents in cleaning and disinfection programs. BMC Infect Dis 2001, 1:16.
22. Russell A.D., McDonnell G. Concentration: a major factor in studying biocidal action. J Hosp Infect 2000, 44:1-3.
23. Lambert R.J., Joynson J., Forbes B. The relationships and susceptibilities of some industrial, laboratory and clinical isolates of Pseudomonas aeruginosa to some antibiotics and biocides. J Appl Microbiol 2001, 91:972-984.
24. Freney J., Husson M.O., Gavini F., et al. Susceptibilities to antibiotics and antiseptics of new species of the family Enterobacteriaceae. Antimicrob Agents Chemother 1988, 32:873-876.
25. Joynson J.A., Forbes B., Lambert R.J. Adaptive resistance to benzalkonium chloride, amikacin and tobramycin: the effect on susceptibility to other antimicrobials. J Appl Microbiol 2002, 93:96-107.
26. Langsrud S., Sundheim G., Holck A.L. Cross-resistance to antibiotics of Escherichia coli adapted to benzalkonium chloride or exposed to stress-inducers. J Appl Microbiol 2004, 96:201-208.
27. Machado E., Canton R., Baquero F., et al. Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother 2005, 49:1823-1829.
28. Campanac C., Pineau L., Payard A., Baziard-Mouysset G., Roques C. Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother 2002, 46:1469-1474.
29. Baquero M.R., Galan J.C., del Carmen Turrientes M., et al. Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005, 49:4754-4756.
30. Galan J.C., Morosini M.I., Baquero M.R., Reig M., Baquero F. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor. Antimicrob Agents Chemother 2003, 47:2551-2557.
31. Jang H.C., Lee S., Song K.H., et al. Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance. J Korean Med Sci 2010, 25:3-8.
32. Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol 2002, 92:55S-64S.
33. Lear J.C., Maillard J.Y., Dettmar P.W., Goddard P.A., Russell A.D. Chloroxylenol- and triclosan-tolerant bacteria from industrial sources. J Ind Microbiol Biotechnol 2002, 29:238-242.
34. Thomas L., Russell A.D., Maillard J.Y. Antimicrobial activity of chlorhexidine diacetate and benzalkonium chloride against Pseudomonas aeruginosa and its response to biocide residues. J Appl Microbiol 2005, 98:533-543.